Featured Content

New Paradigms in the Treatment Options for ALL and AML: European Perspective

New Paradigms in the Treatment of Relapsed Multiple Myeloma

Changing Landscape of Treatment Options for Metastatic Urothelial Carcinoma

Emerging Strategies in the Management of Chronic Fibrosing ILD Patients Who Have Contracted COVID-19


New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia
April 27, 2019
Houston, TX

Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
October 27, 2018
Houston, TX

Emerging Strategies in Novel Targeted Therapies for Genitourinary Cancers (Castrate Resistant Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Carcinoma)
September 22, 2018
Houston, TX

7th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia
June 23, 2018
Houston, TX

3rd Annual Symposium on Individualized Novel Disease-Modifying Treatment Options for Multiple Sclerosis
September 10, 2016
Houston, TX

Biological Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Osteoarthritis: Comparative Effectiveness Based on Treatment Profiles and Guideline Recommendations

September 19, 2015
Philadelphia, PA

2nd Annual Symposium on Current Strategies in the Diagnosis and Treatment of Multiple Sclerosis 

April 11, 2015
Dallas, TX

View All Live Programs